InvestSMART

Respiri Limited (ASX:RSH)

ALERT: Price-sensitive ASX Announcement for RSH
Current share price for RSH : $0.033 -0.015 (-31.25%)+
Announcement
Release
3 Mar 2025 9:44AM
Price at Release
$0.048
Full Release
download
Summary
Respiri Limited is focused on accelerating the commercialization of its Remote Patient Monitoring (RPM) services in the U.S. as part of a capital raising initiative. The company aims to raise A$4 million through an institutional placement, comprising two tranches, to support operational growth while enhancing its healthcare delivery capabilities. With a proprietary device, Wheezo, and a risk-share model, Respiri targets cost reductions in healthcare delivery, aiming for significant market penetration and improved patient outcomes, particularly among high-risk populations. Their strategy includes scaling sales teams, preparing for new contracts, and investing in technology enhancements.
Key Points
  • Respiri is raising A$4 million through an institutional placement.
  • The capital raising consists of two tranches scheduled for March and June 2025.
  • The company targets high-risk populations with its proprietary Wheezo device.
  • Respiri aims to enhance operational efficiency and patient engagement.
  • They plan to scale sales and account management teams.
  • The strategy includes preparing for ACO/IPA contracts and technological enhancements.
  • Respiri forecasts significant market growth and improved patient outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.